Tridiuum, a digital health company headquartered in Philadelphia, has secured a $9.5 million Series B round, which it will use to advance its solution aimed at integrating behavioral health into the continuum of care.
The financing round was led by Sopris Capital. Fresenius Medical Care Ventures, Ben Franklin Technology Partners of Southeastern Pennsylvania and Martinson Ventures participated. Silicon Valley Bank provided debt funding.
In a phone interview, Tridiuum CEO Mark Redlus explained how the company’s product works. Dubbed Tridiuum1, it is a cloud-based, HIPAA-compliant platform.
The tool involves an assessment that patients take in the waiting room. Upon registration, the patient is given a tablet that includes a variety of behavioral health questions. Redlus said the assessment takes about four minutes to complete.
Photo: Tridiuum
The questions are on topics such as depression, anxiety, PTSD, substance abuse and suicidality.
“All of that data that’s generated in real-time from that assessment is synchronized into our cloud-based platform and simultaneously with the EHR of the health systems we’re working with,” Redlus noted.
The provider can then pull up the information on their dashboard during the appointment as a way to engage the patient. Overall, the data can give the provider insights into the patient’s most important behavioral health issues. Through the use of a proprietary metric, Tridiuum1 can also quantify the severity of a patient’s behavioral health issues.
To measure progress over time, the patient can complete an assessment update at subsequent appointments. It usually takes about two or three minutes.
The Philadelphia company counts “more than 10 large-scale health systems” among its clients, Redlus said. He declined to name any specific customers aside from Atrius Health, which is based in Boston.
Tridiuum relies on a SaaS-based business model.
The company’s roots date back to the late 1990s, when it began as a research think tank focused on creating technology to help behavioral health providers with feedback-informed treatment. Over the years, it was awarded funding from the National Institutes of Health. While it used to go by Polaris Health Directions, the company changed its name to Tridiuum in 2017. Just this year, it moved its office from Wayne, Pennsylvania, to Philadelphia.
Looking ahead, Redlus said the $9.5 million will also help Tridiuum spread awareness of its product and regionalize its sales force. “We’ve got some fairly significant product development opportunities with some of our customers that we want to take advantage of,” he added.
Photo: CaptureTheWorld, Getty Images
